Updated:
Brandon Biocatalyst
Brandon Biocatalyst is a venture capital firm headquartered in Melbourne, Australia. It is the largest life‑science investment fund in Australia and New...
Brandon Biocatalyst
Brandon Biocatalyst is a venture capital firm headquartered in Melbourne, Australia. It is the largest life‑science investment fund in Australia and New Zealand. The fund is structured as a collaboration among superannuation funds, CSL, government entities, and more than 50 medical‑research institutes. Its investment mandate centers on transforming biomedical discoveries into market‑ready medical products. By leveraging the expertise of its research‑institute partners, the firm aims to de‑risk early‑stage life‑science technologies. The firm’s strategy emphasizes capital‑efficient development pathways that bridge laboratory breakthroughs to commercialisation. Brandon Biocatalyst’s website (brandonbiocatalyst.com) provides further details on its portfolio and partnership model.
General information
Firm type
Venture Capital
Location
Country
Australia
City
Melbourne
Corporate office
Melbourne, Australia
Sector focus
Frequently asked questions
What sector does Brandon Biocatalyst invest in?
It invests exclusively in life‑science ventures that translate biomedical discoveries into medical products.
Who are the partners behind the fund?
The fund is a collaboration between superannuation funds, CSL, government bodies and over 50 medical‑research institutes.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: